Our Services
Omics from the biobank
to the cloud
Generating omics data from biobank samples makes an invaluable resource for research and public health, a priceless investment in health and innovation for the generations to come. But generating and processing biobank-scale omics data can quickly become overwhelming. Our experts with decades of hands-on experience on omics analyses will be happy to help you generate the data that best suits your needs in a time and cost effective manner.
You plan to acquire data on large number of samples? Scandifran can help you with…
- Selecting the omics technologies and providers that will generate data that best suits your needs and set up data acquisition strategies, in full compliance with national and European regulations on human sample and personal data handling
- Handling the logistics of the omics data acquisition, from the biobank to a secure cloud system
- Data organization, curation, and quality control.
Omics data governance
Unlocking the potential of biobank-scale omics data requires solving technical, organizational, and legal challenges. Building on decades of omics data governance, Scandifran will be happy to help you govern your data so that its potential does not remain buried in a hard drive.
You are responsible for large omics data? Scandifran can help you with…
- Setting up a system for versioning, deletion of data following participant withdrawal, data release, and secure access for third-parties
- Organization, documentation, and maintenance of the data
- Compliance with national and European regulations on personal data handling
You want to use existing biobank-scale omics data? Scandifran can help you with…
- Application for ethical committees, data access, and setting up a data management plan
- Enable cross-border European data management and federated analysis
- Training on secure information systems and large-scale omics
EHDS interfacing and compliance
The European Health Data Space (EHDS) is a groundbreaking initiative to enable secure secondary use of health data for research, innovation, and public health. But turning this vision into reality requires interfacing local data to the EHDS, which poses complex requirements in terms of data governance, permitted purposes, data minimization, and secure processing environments – and these are particularly challenging to implement for omics data. We aim to provide end-to-end solutions for stakeholders to interface to EHDS, ensuring interoperability and adherence to privacy safeguards, while unlocking the full potential of health data for the generations to come.
​
You need to interface health data to the EHDS? Scandifran can help you with…
- Guidance on EHDS governance, permitted purposes, and opt-out principles to ensure lawful secondary use.
- Solutions for harmonizing datasets with EHDS minimum data categories and cross-border standards.
- Deployment and management of compliant environments for pseudonymized data analysis.
- Support for connecting to HealthData@EU and managing secure cross-border data flows, support for establishment of federated analysis tools.
- Services for pseudonymization, data minimization, and monitoring to meet EHDS protection requirements.
What omics data?
We have experience with handling of genomics (genotyping and sequencing), proteomics (affinity- and mass spectrometry-based), and metabolomics (NMR- and mass spectrometry-based) data. You work with other types of data? No problem, we’ll find an expert for you.
What about other data?
Questionnaires, health records, we are happy to help with other types of data, and help you pair these data with your omics data.
The European Health Data Space (EHDS) is a regulatory framework designed to enable secure and standardized sharing of health data across EU member states. It distinguishes between primary use (direct patient care, cohort owners) and secondary use (research, innovation, public health, and policy-making) to maximize societal benefits. EHDS sets clear rules for governance, permitted purposes, and safeguards such as pseudonymization and opt-out rights for individuals. It also establishes HealthData@EU, a cross-border infrastructure for accessing health data securely. By harmonizing data categories and processing environments, EHDS empowers researchers, public bodies, and private actors to responsibly use health data for innovation and better healthcare outcomes.​
What is the EHDS?
​
​Key EHDS targets where Scandifran can help you include:
- Research and innovation with clinical and genomic data, supported under Article 53 (Permitted Purposes) and Article 33 (Minimum Datasets)
- AI development for healthcare, supported under Article 53 (Permitted Purposes) and Article 33 (Minimum Datasets), enabled by Article 53 and subject to Article 36 (Data Minimization & Secure Processing)
- Public Health Monitoring, governed by Article 53 and Article 52 (Cross-border Infrastructure) for EU-wide epidemiological studies.
- Regulatory & Policy Analysis, covered under Chapter IV (Articles 33–58) for lawful secondary use and compliance.
- Prohibited Uses (e.g., Marketing, Insurance Risk Scoring), explicitly banned under Article 53a to protect European citizens.
- EHDS compliance by data holders and access bodies regarding secondary use (Article 73).
Please do not hesitate to get in touch with your requests on biobank-scale omics data, one of our experts will see how Scandifran can help you.